Tooth Loss Predicts Long-Term Prognosis of Esophageal Cancer After Esophagectomy
- 22 Downloads
Oral health is associated with various diseases, including cancer. Tooth loss is a simple and objective index of oral health.
The purpose of this study was to investigate the association between preoperative tooth loss and esophageal cancer prognosis after esophagectomy.
This study included 191 patients who underwent esophagectomy for esophageal cancer after perioperative dental evaluation and oral care at Kobe University Hospital from April 2011 to March 2016. Patients were divided into two groups: Group A (tooth loss < 7) and Group B (tooth loss ≥ 7). Three-year overall survival (OS) and multivariate analysis were performed, along with subgroup analysis for elderly patients (age ≥ 65 years).
The 3-year OS rate was 68.1% in Group A (104 patients) and 49.2% in Group B (87 patients). Group A had significantly higher OS than Group B (p = 0.002), and there were no significant differences in sex and clinical T or N stage between the two groups. However, the mean age of Group A was younger than that of Group B (64.2 vs. 68.5 years; p = 0.0002). Among elderly patients, the 3-year OS rate was 68.2% in Group A (55 patients) and 45.1% in Group B (65 patients) [p = 0.003]. Multivariate analysis that included age demonstrated that tooth loss is an independent prognostic factor (hazard ratio 1.87, 95% confidence interval 1.22–2.87), in addition to clinical T stage and preoperative serum albumin.
Tooth loss is an independent prognostic factor for esophageal cancer after esophagectomy.
There were no sources of financial or material support for this study.
Susumu Miura, Tetsu Nakamura, Takumi Hasegawa, Yukiko Miura, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Satoshi Suzuki, Masaya Akashi, and Yoshihiro Kakeji have no commercial interests related to the subject of the study to disclose.
- 9.Shi J, Leng W, Zhao, et al. Tooth loss and cancer risk: a dose-response meta analysis of prospective cohort studies. Oncotarget. 2017;9:15090–15100.Google Scholar
- 14.Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell; 2010.Google Scholar
- 17.Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.CrossRefGoogle Scholar
- 23.Nassri A, Zhu H, Wang DH, Ramzan Z. Serum albumin at diagnosis is an independent predictor of early mortality in veteran patients with esophageal cancer. Nutr Cancer. 2018;20:1–8.Google Scholar
- 25.Pan YP, Hsu TY, Lin JY, et al. Prognostic significance of low body mass index and Betel-Quid use in the 5-year survival rates of esophageal squamous cell carcinoma patients. Nutr Cancer. 2019;22:1–7.Google Scholar